Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry into a Material Definitive Agreement.
Share Exchange Agreement. On November 12,
2026, GridAI Technologies Corp. (the “Company”) entered into a Share Exchange Agreement (as amended by the Addendum
(as defined below), the “Exchange Agreement”) by and among the Company, Pronghorn Resources, LLC, a Delaware limited liability
company (“Pronghorn”), the members of Pronghorn identified therein (collectively, the “Sellers”), and Nicholas
D'Onofrio, as representative of the Sellers. Pursuant to the Exchange Agreement, the Sellers will transfer to the Company all of the issued
and outstanding membership units of Pronghorn (the “Units”) in exchange for an aggregate of (i) 1,247,887 shares of the Company’s
common stock, par value $0.0001 per share (the “Common Stock”), which, together with the 794,110 shares of Common Stock issuable
to Sigma9 (as defined below), represent 19.99% of the shares of Common Stock outstanding prior to the closing, and (ii) up to 129,504.23
shares of the Company’s newly designated Series I Convertible Preferred Stock, par value $0.0001 per share (the “Series I
Preferred Stock”), including the Escrow Shares and the Milestone Shares (each as defined below), initially convertible into an aggregate
of 64,752,113 shares of Common Stock, for total consideration representing 66,000,000 common-equivalent shares (the “Share Exchange”).
Upon the closing of the Share Exchange (the date of such closing, the “Closing Date”), Pronghorn will become a wholly owned
subsidiary of the Company. Concurrently with the execution of the Exchange Agreement, the parties entered into an Addendum dated as of
the same date (the “Addendum”), that requires Pronghorn to deliver a final list of the Sellers, and any required FIRPTA documentation,
within 10 days. The closing of the Share Exchange is only conditioned upon Pronghorn delivering the final list of the Sellers and compliance
with FIRPTA. The closing is expected to occur no later than November 23, 2026.
Each share of Series I Preferred Stock has an
original issue price and liquidation value of $1,000 and is convertible into shares of Common Stock at an initial conversion price of
$2.00 per share (an initial conversion ratio of 500 shares of Common Stock per share of Series I Preferred Stock). The Series I Preferred
Stock may not be converted until (i) the Company’s stockholders approve the conversion in accordance with Nasdaq listing rules (the
“Stockholder Approval”) and (ii) Nasdaq has approved the listing of the shares of Common Stock issuable upon conversion. Conversion
is further subject to a beneficial ownership limitation initially set at 9.99%, which a holder may adjust to between 4.99% and 19.99%;
any increase above the then-applicable limitation is not effective until the 61st day after notice to the Company, and the limitation
may not be waived. Effective automatically upon the approval, if and when received, of the Company’s stockholders for, the conversion
of the outstanding shares of the Company’s Series H Convertible Preferred Stock and receipt of any required Nasdaq approval (the
“Series H Conversion”), each outstanding share of Series I Preferred Stock will be adjusted to equal 2.74724 shares of Series
I Preferred Stock assuming the full conversion of the Series H Convertible Preferred Stock into 38,801,546 shares of Common Stock, whether
the Series H Conversion occurs before or after issuance,. Upon such adjustment, the Series I Preferred Stock issued to the Sellers would
represent approximately 355,779.20 shares of Series I Preferred Stock, convertible into approximately 177,889,600 shares of Common Stock.
In the event that the Series H Convertible Preferred Stock becomes convertible or exchangeable into a different number, the adjustment
factor and the number of shares of Series I Preferred Stock and shares of Common Stock issuable upon conversion thereof shall be adjusted
accordingly. The Series I Preferred Stock has no voting rights except as required by the Delaware General Corporation Law until receipt
of the Stockholder Approval, is not entitled to dividends except as required by law, is perpetual and not redeemable, and ranks senior
to junior securities, on parity with the Company’s previously designated series of preferred stock and junior to any senior securities
upon liquidation. Until the Stockholder Approval has been obtained and the shares of Common Stock issuable upon conversion of the Sellers’
Series I Preferred Stock (the “Exchange Conversion Shares”) have been registered, for resale under an effective registration
statement, the Company may not, without the consent of the holders of a majority of the outstanding Series I Preferred Stock, among other
things, incur indebtedness for borrowed money (other than Pronghorn working capital facilities in the ordinary course), adversely amend
the rights of the Series I Preferred Stock, create senior equity securities, pay dividends on Common Stock or junior securities, make
capital expenditures in excess of $500,000 outside the ordinary course without Board approval, or divert the Pronghorn working capital
reserve. Of the shares of Series I Preferred Stock issued to the Sellers, 13,200 shares (the “Escrow Shares”) are being held
by the Company following the closing as security for the Sellers’ indemnification obligations under the Exchange Agreement. Following
the expiration of the initial 18-month survival period, up to 13,200 Escrow Shares will be released to the Sellers if pending indemnification
claims do not exceed the value of the remaining Escrow Shares, and the remaining Escrow Shares will be released, less shares retained
for unresolved claims, following the expiration of the remaining applicable indemnification period. In addition, 6,600 shares of Series
I Preferred Stock (the “Milestone Shares”) are being held by the Company and will be issuable to the Sellers only upon written
notice from the Sellers’ representative that Pronghorn has completed at least 120 qualifying well workovers during the period from
November 1, 2026 through April 30, 2027.
The Exchange Agreement contains customary representations,
warranties, covenants and indemnification provisions. Pursuant to the Exchange Agreement, the Company has agreed, among other things,
to (i) use its reasonable best efforts to hold a meeting of its stockholders to obtain the Stockholder Approval, together with approval
of an increase in the number of authorized shares of Common Stock to 500,000,000, within 90 days following the Closing Date, subject to
extension to obtain the audited financial statements of Pronghorn, but in no event later than 180 days following the Closing Date; and
(ii) maintain a working capital reserve of $10,000,000, less the principal amount funded under the Note (as defined below), from
the net proceeds of the Company’s financing as a working capital reserve to be used solely for the business of Pronghorn. In addition,
the Sellers have the right to designate one director to the Board of Directors of the Company (the “Board”) at the closing,
and one additional director following receipt of the Stockholder Approval, in each case subject to the Company’s consent (not to
be unreasonably withheld) and Nasdaq independence and qualification requirements. For so long as the Sellers collectively hold at least
10% of the outstanding Common Stock (on an as-converted basis), the Sellers will have the continuing right to designate two directors
for nomination to the Board at each annual meeting, and for so long as the Sellers collectively hold at least 30% of the outstanding Common
Stock (on an as-converted basis), the Company may not increase the size of the Board above five members without the consent of the holders
of a majority of the Sellers’ Series I Preferred Stock. Prior to the appointment of the second Seller designee, the Sellers
are also entitled to appoint one non-voting Board observer.
Closing Deliverables. Pursuant to the Exchange
Agreement, at the closing of the Share Exchange, (i) the Company and the Sellers will enter into a registration rights agreement providing
for, among other things, the registration for resale of the shares of Common Stock issued to the Sellers and issuable upon conversion
of their Series I Preferred Stock, with liquidated damages payable if a registration statement is not effective within 180 days following
the filing deadline; (ii) each Seller will enter into a voting agreement agreeing to vote its share in favor of the Company’s slate
of director nominees, subject to the Company’s compliance with the Sellers’ board designation rights; (iii) each Seller will
enter into a lock-up agreement restricting transfers of the shares received in the Share Exchange and the shares issuable upon conversion
thereof for 30 months following the Closing Date; and (iv) the Company will amend the $5,000,000 Amended and Restated Secured Convertible
Note dated October 21, 2026 issued by Pronghorn to the Company (the “Note”) to delete the Company’s right to convert
the Note upon a default thereunder. The Company expects to describe these agreements and file them as exhibits to the Current Report on
Form 8-K reporting the closing of the Share Exchange.
Stockholder Support Agreements. In connection
with the Exchange Agreement, certain of the Company’s officers, directors and stockholders entered into Stockholder Support Agreements
with the Company (the “PubCo Support Agreements”), pursuant to which each such stockholder agreed, until the earliest of the
receipt of the Stockholder Approval, the termination of the Exchange Agreement prior to closing and the shareholder meeting deadline under
the Exchange Agreement, to vote all of its shares of Common Stock in favor of the matters submitted for the Stockholder Approval (including
the increase in authorized shares of Common Stock and the conversion of the Series I Preferred Stock) and against any competing proposal,
and granted the Company an irrevocable proxy to vote such shares accordingly. Each stockholder also agreed not to transfer all of its
shares, subject to customary exceptions, and not to solicit alternative acquisition proposals, and waived appraisal rights. Following
the closing, the Sellers’ representative is a third-party beneficiary entitled to enforce the PubCo Support Agreements.
Sigma9 Assignment.
Concurrently with the closing of the Share Exchange, the Company expects to enter into an Assignment and Assumption Agreement (the “Assignment
Agreement”) with SIGMA9 Capital Ltd., a Cayman Islands exempted company (“Sigma9”), acknowledged by 1st American
Nuclear Co., a Delaware corporation (“FANCO”), pursuant to which Sigma9 will assign to the Company its rights and obligations
under an Amended and Restated Joint Venture Agreement with FANCO relating to the development of small modular reactor power generation
facilities in Wyoming, in exchange for 794,110 shares of Common Stock and 82,411.78 shares of Series I Preferred Stock. The Company
expects to describe the Assignment Agreement and file it as an exhibit to the Current Report on Form 8-K reporting the closing of
the Share Exchange.
The foregoing descriptions of the Exchange Agreement
and the PubCo Support Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of such
agreements, copies or forms of which are filed as Exhibits 2.1 and 10.1, respectively, to this Current Report on Form 8-K and are
incorporated herein by reference. The representations, warranties and covenants contained in such agreements were made solely for the
benefit of the parties thereto, may be subject to limitations agreed upon by the contracting parties and should not be relied upon by
investors as characterizations of the actual state of facts or condition of the Company, Pronghorn or any other party.